About Psylo
Psylo is a company based in Sydney (Australia) founded in 2021 by Josh Ismin and Sam Banister.. Psylo has raised $14.18 million across 3 funding rounds from investors including Focalpoint Partners, Main Sequence and Lionheart Ventures. Psylo offers products and services including Neuroplastogen Therapies and Pipeline Therapies. Psylo operates in a competitive market with competitors including ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Cybin, among others.
- Headquarter Sydney, Australia
- Founders Josh Ismin, Sam Banister
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Psylo Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.18 M (USD)
in 3 rounds
-
Latest Funding Round
$8 M (USD), Seed
Jun 03, 2024
-
Investors
Focalpoint Partners
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Psylo
Psylo offers a comprehensive portfolio of products and services, including Neuroplastogen Therapies and Pipeline Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments enhancing neuroplasticity for brain disorders.
Advanced tools for developing neurological treatments.
Unlock access to complete
Leadership Team
3 people
Lead Team
1 people
Head Team
1 people
Computational Team
1 people
Medicinal Team
1 people
Unlock access to complete
Funding Insights of Psylo
Psylo has successfully raised a total of $14.18M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $8 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $8.0M
-
First Round
First Round
(01 Oct 2021)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Seed - Psylo | Valuation | Tenmile | |
| Oct, 2022 | Amount | Seed - Psylo | Valuation | Main Sequence | |
| Oct, 2021 | Amount | Seed - Psylo | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Psylo
Psylo has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Focalpoint Partners, Main Sequence and Lionheart Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in deep tech founders.
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on transformative technologies is operated.
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in health and technology sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Psylo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Psylo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Psylo Comparisons
Competitors of Psylo
Psylo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, COMPASS Pathways, MindMed, Beckley Psytech and Cybin, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Therapies for mental disorders, including psilocybin for depression, are developed.
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapies for brain health disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of neurological and psychiatric disorders
|
|
| domain | founded_year | HQ Location |
Psychedelic therapeutics for psychiatric disorders are developed and provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Psylo
Frequently Asked Questions about Psylo
When was Psylo founded?
Psylo was founded in 2021.
Where is Psylo located?
Psylo is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Who is the current CEO of Psylo?
Josh Ismin is the current CEO of Psylo. They have also founded this company.
Is Psylo a funded company?
Psylo is a funded company, having raised a total of $14.18M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.18M, raised on Oct 01, 2021.
What does Psylo do?
Psylo was founded in 2021 in Sydney, Australia, as a developer of psychedelic-derived therapeutics targeting mental health conditions. Improved treatments against selective serotonin reuptake inhibitors are provided through these drugs, addressing issues such as treatment-resistant depression, anxiety, and addiction. Operations focus on research and development within the biotechnology sector, with activities centered in Australia.
Who are the top competitors of Psylo?
Psylo's top competitors include MindMed, COMPASS Pathways and Beckley Psytech.
What products or services does Psylo offer?
Psylo offers Neuroplastogen Therapies and Pipeline Therapies.
Who are Psylo's investors?
Psylo has 13 investors. Key investors include Focalpoint Partners, Main Sequence, Lionheart Ventures, Negev Capital, and XEIA Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.